Across TCGA pan-cancer cohorts, H2BC19P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated H2BC19P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher H2BC19P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated H2BC19P expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

ACC, KIRP, and UVM are the cancer types where H2BC19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.349	0.814	<.001	105	view →
KIRP	DFS	Median	All	0.781	0.923	<.001	78	view →
UVM	DFS	Median	III,IV	0.238	0.850	<.001	72	view →
UCEC	DFS	Quartile	All	0.576	0.736	.002	38	view →
KIRC	DFS	Median	All	0.557	0.725	.001	37	view →
LIHC	DFS	Median	All	0.357	0.516	<.001	35	view →
HNSC	OS	Median	IV	0.497	0.286	<.001	34	view →
COAD	DFS	Tertile	All	0.682	0.864	<.001	26	view →
MESO	OS	Tertile	All	0.234	0.754	.012	18	view →
OV	DFS	Median	IV	0.390	0.222	.016	18	view →
THYM	DFS	Quartile	II,III,IV	0.945	0.429	.003	14	view →
ESCA	DFS	Quartile	All	0.333	0.548	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

Exploration

Same gene, other analysis: H2BC19P tumor-vs-normal RNA expression · all H2BC19P data types